SOURCE: Kiwa Bio-Tech Products Group Corporation

Kiwa Bio-Tech Products Group Corporation

July 13, 2016 09:00 ET

KIWA Begins Trading on OTCQB

CLAREMONT, CA--(Marketwired - Jul 13, 2016) -  Kiwa Bio-Tech Products Group Corporation (OTCQB: KWBT) announced that its common stock has been approved to trade on the OTCQB effective July 13, 2016 under the same symbol "KWBT".

"Having our stock traded on the OTCQB marketplace represents a significant step in upgrading its trading platform from the Pink Sheets. We are hopeful that this move will enhance the liquidity of our stock and bring new investors into the Company," said Yvonne Wang, Kiwa's COO. "With the support of Chinese government action to protect the soil environment and pollution resulting from traditional fertilizers, we continue to be on track in the development and marketing of our environmentally friendly fertilizers in the Chinese market. We continue to focus on the growth of our business in Hunan, Hainan, Xinjiang and other provinces, which we expect will produce increased sales in the future consistent with development strategy."

About Kiwa Bio-Tech Products Group Corporation

We develop, manufacture, distribute and market innovative, cost-effective and eco-friendly bio-technological products for agriculture. Our main product groups are bio-fertilizer, biologically enhanced livestock feed. Our products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. Our businesses include bio-fertilizer and bio-enhanced feed.

Kiwa's strategy is to implement increased visibility for marketing Kiwa's current bio-fertilizer products, together with the development of a "green agriculture" safe food platform in China. Our goal is to build market penetration for our Kiwa brand in China's trillion dollar "green" agricultural produce market.

For more information on Kiwa and its products, please refer to the Company's website at www.kiwabiotech.com or the Company filings with the United States Securities and Exchange Commission, available for free at www.sec.gov.

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

Contact Information